These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27656207)

  • 1. Differences in miRNA and mRNA Profile of Papillary Thyroid Cancer Variants.
    Stokowy T; Gawel D; Wojtas B
    Int J Endocrinol; 2016; 2016():1427042. PubMed ID: 27656207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminatory miRNAs for the Management of Papillary Thyroid Carcinoma and Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features.
    Jahanbani I; Al-Abdallah A; Ali RH; Al-Brahim N; Mojiminiyi O
    Thyroid; 2018 Mar; 28(3):319-327. PubMed ID: 29378472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma.
    Dettmer M; Perren A; Moch H; Komminoth P; Nikiforov YE; Nikiforova MN
    Thyroid; 2013 Nov; 23(11):1383-9. PubMed ID: 23427895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.
    Shi X; Liu R; Basolo F; Giannini R; Shen X; Teng D; Guan H; Shan Z; Teng W; Musholt TJ; Al-Kuraya K; Fugazzola L; Colombo C; Kebebew E; Jarzab B; Czarniecka A; Bendlova B; Sykorova V; Sobrinho-Simões M; Soares P; Shong YK; Kim TY; Cheng S; Asa SL; Viola D; Elisei R; Yip L; Mian C; Vianello F; Wang Y; Zhao S; Oler G; Cerutti JM; Puxeddu E; Qu S; Wei Q; Xu H; O'Neill CJ; Sywak MS; Clifton-Bligh R; Lam AK; Riesco-Eizaguirre G; Santisteban P; Yu H; Tallini G; Holt EH; Vasko V; Xing M
    J Clin Endocrinol Metab; 2016 Jan; 101(1):264-74. PubMed ID: 26529630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA Expression Profiling-Potential Molecular Discrimination of Papillary Thyroid Carcinoma Subtypes.
    Silaghi H; Pop LA; Georgescu CE; Muntean D; Crișan D; Silaghi P; Lungu I; Nasui BA; Dulf EH; Braicu C; Berindan-Neagoe I; Silaghi CA
    Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papillary Thyroid Carcinoma Variants are Characterized by Co-dysregulation of Immune and Cancer Associated Genes.
    Chakladar J; Li WT; Bouvet M; Chang EY; Wang-Rodriguez J; Ongkeko WM
    Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31443155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis.
    Zhang C; Bo C; Guo L; Yu P; Miao S; Gu X
    World J Surg Oncol; 2019 Dec; 17(1):221. PubMed ID: 31842912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptomic Analysis Reveals Dysregulation of the Mycobiome and Archaeome and Distinct Oncogenic Characteristics according to Subtype and Gender in Papillary Thyroid Carcinoma.
    John D; Yalamarty R; Barakchi A; Chen T; Chakladar J; Li WT; Ongkeko WM
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated microRNA, gene expression and transcription factors signature in papillary thyroid cancer with lymph node metastasis.
    Ab Mutalib NS; Othman SN; Mohamad Yusof A; Abdullah Suhaimi SN; Muhammad R; Jamal R
    PeerJ; 2016; 4():e2119. PubMed ID: 27350898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.
    Saiselet M; Gacquer D; Spinette A; Craciun L; Decaussin-Petrucci M; Andry G; Detours V; Maenhaut C
    BMC Genomics; 2015 Oct; 16():828. PubMed ID: 26487287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of novel target genes and pathways involved in tall cell variant papillary thyroid carcinoma.
    Xia F; Jiang B; Chen Y; Du X; Peng Y; Wang W; Wang Z; Li X
    Medicine (Baltimore); 2018 Dec; 97(51):e13802. PubMed ID: 30572540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of key genes and miRNAs markers of papillary thyroid cancer.
    Qiu J; Zhang W; Zang C; Liu X; Liu F; Ge R; Sun Y; Xia Q
    Biol Res; 2018 Nov; 51(1):45. PubMed ID: 30414611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of key miRNAs in papillary thyroid carcinoma based on data mining and bioinformatics methods.
    Wang J; Wu L; Jin Y; Li S; Liu X
    Biomed Rep; 2020 Jan; 12(1):11-16. PubMed ID: 31839944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IRAK1, a Target of miR-146b, Reduces Cell Aggressiveness of Human Papillary Thyroid Carcinoma.
    Chou CK; Chi SY; Huang CH; Chou FF; Huang CC; Liu RT; Kang HY
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4357-4366. PubMed ID: 27533309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for central neck lymph node metastases in follicular variant vs. classic papillary thyroid carcinoma.
    Raffaelli M; De Crea C; Sessa L; Fadda G; Lombardi CP; Bellantone R
    Endocrine; 2018 Oct; 62(1):64-70. PubMed ID: 29770933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of TSPAN13 by miR-369-3p inhibits cell proliferation in papillary thyroid cancer (PTC).
    Li P; Dong M; Wang Z
    Bosn J Basic Med Sci; 2019 May; 19(2):146-154. PubMed ID: 30114378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma.
    Minna E; Romeo P; Dugo M; De Cecco L; Todoerti K; Pilotti S; Perrone F; Seregni E; Agnelli L; Neri A; Greco A; Borrello MG
    Oncotarget; 2016 Mar; 7(11):12731-47. PubMed ID: 26871295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Panel of Plasma Exosomal miRNAs as Potential Biomarkers for Differential Diagnosis of Thyroid Nodules.
    Liang M; Yu S; Tang S; Bai L; Cheng J; Gu Y; Li S; Zheng X; Duan L; Wang L; Zhang Y; Huang X
    Front Genet; 2020; 11():449. PubMed ID: 32508877
    [No Abstract]   [Full Text] [Related]  

  • 19. Uncovering the potential miRNAs and mRNAs in follicular variant of papillary thyroid carcinoma in the Cancer Genome Atlas database.
    Li M; Zhao B; Qu W; Zhang Z; Jiang Z
    Transl Cancer Res; 2019 Aug; 8(4):1158-1169. PubMed ID: 35116858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A population-based study of the three major variants of papillary thyroid carcinoma.
    Xu J; Zhang Y; Liu J; Qiu S; Wang M
    J Int Med Res; 2021 Feb; 49(2):300060520984618. PubMed ID: 33535844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.